Preface
Focused issue on urological oncology
Translational Andrology and Urology
2015;
4
(3)
:243
.
(28 June 2015)
Review Article
Bacille-Calmette-Guerin non-responders: how to manage
Translational Andrology and Urology
2015;
4
(3)
:244-253
.
(28 June 2015)
Standard cystectomy fits all: truth or myth?
Translational Andrology and Urology
2015;
4
(3)
:254-260
.
(28 June 2015)
Upper urinary tract disease: what we know today and unmet needs
Translational Andrology and Urology
2015;
4
(3)
:261-272
.
(28 June 2015)
Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer
Translational Andrology and Urology
2015;
4
(3)
:273-282
.
(28 June 2015)
Indications for biopsy and the current status of focal therapy for renal tumours
Translational Andrology and Urology
2015;
4
(3)
:283-293
.
(28 June 2015)
Outlining the limits of partial nephrectomy
Translational Andrology and Urology
2015;
4
(3)
:294-300
.
(28 June 2015)
Cytoreductive surgery in the era of targeted molecular therapy
Translational Andrology and Urology
2015;
4
(3)
:301-309
.
(28 June 2015)
Sequence of treatment in locally advanced and metastatic renal cell carcinoma
Translational Andrology and Urology
2015;
4
(3)
:310-325
.
(28 June 2015)
The current and future role of magnetic resonance imaging in prostate cancer detection and management
Translational Andrology and Urology
2015;
4
(3)
:326-341
.
(28 June 2015)
Active surveillance and focal therapy for low-intermediate risk prostate cancer
Translational Andrology and Urology
2015;
4
(3)
:342-354
.
(28 June 2015)
Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
Translational Andrology and Urology
2015;
4
(3)
:355-364
.
(28 June 2015)
Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
Translational Andrology and Urology
2015;
4
(3)
:365-380
.
(28 June 2015)
Advances in the treatment of testicular cancer
Translational Andrology and Urology
2015;
4
(3)
:381-390
.
(28 June 2015)
Disclosure:
The focused issue “Urological Oncology” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. George N. Thalmann served as the unpaid Guest Editor for the focused issue.
